| Literature DB >> 28402073 |
Chelsey J Forbess Smith1, Sheila Fallon Friedlander2, Monica Guma1, Arthur Kavanaugh1, Christina D Chambers3,4.
Abstract
Infantile hemangiomas (IHs) are the most common vascular tumors in infants, appearing in early infancy and ultimately regressing with time. Clinical presentation may vary, with a minority of lesions causing impairment of vital function (e.g., respiratory or visual obstruction), permanent scarring, and/or disfigurement. The pathogenesis of IH is complex and poorly understood. Risk factors implicated in their development include preterm birth and placental anomalies. IH presents a myriad of clinical challenges, including correct diagnosis and whether or not to pursue treatment. This article is a review of the current literature regarding pathogenesis, clinical presentation, treatment, and prognosis of IH. Birth Defects Research 109:809-815, 2017.Entities:
Keywords: beta blockade; glucose transporter-1 (GLUT-1); hemangioma; hypoxia; pregnancy; vascular endothelial growth factor (VEGF)
Mesh:
Year: 2017 PMID: 28402073 PMCID: PMC5839165 DOI: 10.1002/bdr2.1023
Source DB: PubMed Journal: Birth Defects Res Impact factor: 2.344